Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL277533 | 1.00 | EPHX1 (0.36) | EPHX1THRBMEN1KMT2AGABRR1 | |
| SCHEMBL18428581 | 1.00 | EPHX1 (0.36) | EPHX1THRBMEN1KMT2AGABRR1 | |
| SCHEMBL727317 | 1.00 | EPHX1 (0.36) | EPHX1THRBMEN1KMT2AGABRR1 | |
| SCHEMBL8353641 | 0.96 | EPHX1 (0.41) | EPHX1THRBMEN1KMT2ATP53 | |
| SCHEMBL5414023 | 0.96 | EPHX1 (0.41) | EPHX1THRBMEN1KMT2ATP53 | |
| SCHEMBL23803095 | 0.96 | EPHX1 (0.35) | EPHX1THRBMEN1KMT2AGABRR1 | |
| Hydrochloric Acid SCHEMBL25267551 | 0.96 | KDM4E (0.36) | EPHX1THRBMEN1KMT2AGABRR1 | |
| SCHEMBL4967294 | 0.92 | — | — | |
| SCHEMBL21034603 | 0.87 | SIGMAR1 (0.37) | EPHX1SIGMAR1 | |
| SCHEMBL14672056 | 0.85 | TDP1 (0.41) | GABRR1TP53GABRR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114854196-B | Polyimide film | 株式会社斗山 | 2024-05-28 | — | — | CN | disclosed |
| CN-115298248-B | Polyimide film having moisture absorption resistance and water absorption resistance | 株式会社斗山 | 2024-03-08 | — | — | CN | disclosed |
| US-20240034838-A1 | POLYAMIC ACID RESIN AND POLYIMIDE FILM USING THE SAME | DOOSAN CORPORATION (KR) | 2024-02-01 | — | — | US | disclosed |
| CN-117430808-A | Polyamic acid resin and transparent polyimide film using same | 株式会社斗山 | 2024-01-23 | — | — | CN | disclosed |
| EP-3133108-B1 | FIBER-REINFORCED COMPOSITE MATERIAL | MITSUBISHI GAS CHEMICAL CO (JP) | 2023-08-02 | — | — | EP | disclosed |
| CN-115011116-A | Polyimide film | 株式会社斗山 | 2022-09-06 | — | — | CN | disclosed |
| CN-114854196-A | Polyimide film | 株式会社斗山 | 2022-08-05 | — | — | CN | disclosed |
| CN-113260676-A | Polyimide film having excellent weather resistance | 株式会社斗山 | 2021-08-13 | — | — | CN | disclosed |
| CN-113260675-A | Polyimide film having excellent yield strain and bending characteristics | 株式会社斗山 | 2021-08-13 | — | — | CN | disclosed |
| WO-2021117960-A1 | POLYIMIDE FILM HAVING EXCELLENT YIELD STRAIN AND FLEXURAL CHARACTERISTICS | 주식회사 두산 | 2021-06-17 | — | — | WO | disclosed |
| US-20080176854-A1 | Nitro-Substituted Phenyl-Piperazine Compounds, Their Preparation and Use in Medicaments | LABORATORIOS DEL DR. ESTEVE S.A (ES) | 2008-07-24 | — | — | US | disclosed |
| WO-2008034815-A1 | COMBINATION OF NMDA- RECEPTOR LIGAND AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2008-03-27 | — | — | WO | disclosed |
| EP-1902733-A1 | Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2008-03-26 | — | — | EP | disclosed |
| WO-2007147883-A1 | COMBINATION OF A CHOLINESTERASE INHIBITOR AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-12-27 | — | — | WO | disclosed |
| EP-1851210-A2 | NITRO-SUBSTITUTED PHENYL-PIPERAZINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-11-07 | — | — | EP | disclosed |
| EP-1844031-A1 | SUBSTITUTED PHENYL-PIPERAZINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-10-17 | — | — | EP | disclosed |
| EP-1695971-A1 | Substituted phenyl-piperazine compounds, their preparation and use in medicaments | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2006-08-30 | — | — | EP | disclosed |
| WO-2006069807-A1 | SUBSTITUTED PHENYL-PIPERAZINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2006-07-06 | — | — | WO | disclosed |
| WO-2006069808-A2 | NITRO-SUBSTITUTED PHENYL-PIPERAZINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2006-07-06 | — | — | WO | disclosed |
| EP-1676842-A1 | Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2006-07-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080176854-A1 | Nitro-Substituted Phenyl-Piperazine Compounds, Their Preparation and Use in Medicaments | HTR6, HTR5A, P2RX5 | EPHX1 2849/4885THRB 2783/4885MEN1 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.